Which medications in the drug class Rapid-acting insulins are used in the treatment of Glucose Intolerance?

Updated: Jun 28, 2019
  • Author: Samuel T Olatunbosun, MD, FACP, FACE; Chief Editor: George T Griffing, MD  more...
  • Print
Answer

Rapid-acting insulins

Rapid-acting insulins have a short duration of action and are appropriate before meals or when blood glucose levels exceed target levels and correction doses are needed. These agents are associated with less hypoglycemia than regular insulin.

Insulin aspart (NovoLog)

Insulin aspart has a short onset of action of 5-15 minutes and a short duration of action of 3-5 hours. The peak effect occurs within 30-90 minutes. Insulin aspart is FDA approved for use in insulin pumps.

Insulin glulisine (Apidra)

Insulin glulisine has a rapid onset of action of 5-15 minutes and a short duration of action of 3-5 hours. The peak effect occurs within 30-90 minutes. Insulin glulisine is FDA approved for use in insulin pumps.

Insulin lispro (Humalog)

Insulin lispro has a rapid onset of action of 5-15 minutes and a short duration of action of 4 hours.

Insulin inhaled (Afrezza)

Inhaled human insulin is identical, in structure, to that of native human insulin. It is absorbed into carrier particles which dissolve within the lungs after inhalation. This leads to rapid absorption of insulin in the systemic circulation. Inhaled insulin is an ultra-rapid acting insulin.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!